Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Giraffe research broadcast on National Geographic channel
2016-03-09

Description: Giraffe research  Tags: Giraffe research

A documentary focusing on the latest and most interesting research about giraffes was recently broadcasted on National Geographic. Dr Francois Deacon from the UFS Department of Animal, Wildlife and Grassland Sciences and the team of researchers working with him, were first in the world to equip giraffes with GPS collars, and to conduct research on them.

Research by Dr Francois Deacon, from the UFS Department of Animal, Wildlife and Grassland Sciences, involving the equipping of giraffes with GPS collars, was broadcast this week as part of a documentary (4 March 2016 and subsequent weeks) on National Geographic (Channel 182). The documentary is the first of two on his team's research.

Dr Deacon and the team of researchers working with him were the first in the world to equip giraffes with GPS collars, and to conduct research on this initiative. The group of researchers can now follow the animals night and day by means of the GPS collars, while monitoring their movements from a distance on a computer screen and seeing the world from a giraffe's perspective.

“The documentary focuses on the latest and interesting information about our research in different countries,” Dr Deacon said. Besides their local research on giraffes, he and his team also assist in other projects and research in Namibia, Botswana, Zambia, Kenya, the Democratic Republic of the Congo, and Uganda.

“There is much to learn from the documentary,” Dr Deacon said. Interesting facts from their research include herd interactions by individuals towards each other, bulls versus bulls, and cows versus calves. In the documentary, the viewer can also learn how giraffes use thermoregulation, their tongues, and roaming areas and distances; peculiar behaviour such as feeding on bones and soil; bulls fighting; how and when giraffes drink water; and the conservation and management of giraffes.
 
Focus is also placed on the manner in which the latest research plays a role in the better understanding of the animals.
 
According to Dr Deacon, this is the first documentary to focus on giraffe research on such a large scale. Marco Polo Films from Terra Mater are contracted by National Geographic to produce nature films – this was the hundredth nature film produced by them.
 
“There has never before been such a production about giraffes. It also attracted huge interest and reaction overseas, which will provide great exposure for our research and for the UFS.
 
“We believe that the media involvement will provide much more exposure to giraffes, which is a good thing, since they are facing extinction in Africa. The exposure can, in itself, lead to new research and has already started attracting international students to the UFS,” Dr Deacon said.
 
The second documentary will follow later this year. Iniosante, a film team from Texas, USA, is producing this film, which focuses on the extinction of giraffes. It is the same team responsible for the production Last of the Longnecks.



Additional resources:


-    Last of the Longnecks (trailer)
-    Giraffe – Up high and personal (National Geographic video)
-    Giraffe: African Giant (National Geographic video)
-    Giraffe – Up high and personal (article)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept